Literature DB >> 31741245

Effects of Melatonin on the Body Composition, Physical Performance, and Blood Erythrocyte Indexes of C57Bl/6J Mice Exposed to Continuous Illumination.

S V Michurina1, I Yu Ishchenko2, M A Korolev2, A Yu Letyagin2,3, L N Rachkovskaya2, A S Khotskina3, N V Khotskin3, S O Maslennikova3, E L Zavjalov3.   

Abstract

Male C57Bl/6J mice were exposed to daily 24-h illumination over 14 days and daily intragastrically received melatonin (1 mg/kg) or water (placebo). Controls were kept under standard day/night (14/10 h) conditions. Melatonin prevented the development of anemia in mice exposed to continuous illumination, which was proven by higher blood hemoglobin levels by the end of the experiment in melatonin-treated animals in comparison with the placebo group. Studies by the low-field NMR spectrometry detected lower lean body mass, total body water, and especially, fat content (by ~13%) in animals receiving placebo. Melatonin treatment led to an increase in the lean body mass and total body water on day 7 (in comparison with the placebo group) without affecting fat mass. On day 14 of continuous illumination, lean body mass increased in comparison with the corresponding parameter in the control and placebo groups. Melatonin had no effect on the physical endurance of mice exposed to continuous illumination (assessed by the grid hanging test).

Entities:  

Keywords:  body composition; continuous illumination; hemoglobin; melatonin; physical endurance

Mesh:

Substances:

Year:  2019        PMID: 31741245     DOI: 10.1007/s10517-019-04638-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Effect of Melatonin on the Expression of LYVE-1 Receptor in Liver Sinusoidal Endothelial Cells of Mice with the Light-Induced Functional Pinealectomy Model.

Authors:  I Yu Ishchenko; S V Michurina; S A Arkhipov
Journal:  Bull Exp Biol Med       Date:  2022-06-23       Impact factor: 0.804

2.  Melatonin increased hypoxia-inducible factor (HIF) by inhibiting prolyl hydroxylase: A hypothesis for treating anaemia, ischaemia, and covid-19.

Authors:  Mohammad Hossein Hosseinzadeh; Amin Goodarzi; Mohammad Malekan; Mohammad Ali Ebrahimzadeh
Journal:  Clin Exp Pharmacol Physiol       Date:  2022-03-25       Impact factor: 2.963

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.